Clinical Trial Update: A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial sponsored by Octant, Inc. is recruiting healthy volunteers and participants with autosomal dominant retinitis pigmentosa (RHO-adRP) t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Snippet

Sponsor: Octant, Inc. | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: RECRUITING